Actively Recruiting
Financial Toxicity in Patients With Early-stage Breast Cancer
Led by National Cancer Institute, Naples · Updated on 2026-01-21
864
Participants Needed
1
Research Sites
465 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.
CONDITIONS
Official Title
Financial Toxicity in Patients With Early-stage Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent form
- Age > 18 years at the time of study entry
- Histologically confirmed stage I-III invasive breast carcinoma before starting any systemic treatment.
You will not qualify if you...
- Stage IV invasive breast carcinoma
- Major cognitive dysfunction or psychiatric disorders
- Any previous systemic treatment for the current breast cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Cancer Institute of Napoli
Naples, Italy
Actively Recruiting
Research Team
M
Maria Lucia Iacovino, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here